Katharina Cima

Katharina Cima

Auto-generated profile, based on publicly available information

Katharina Cima

Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2022 in Radiology
Verified
Journal Article
Closed access
ALAnna Katharina Luger
Anna Katharina Luger
TSThomas Sonnweber
Thomas Sonnweber
LGLeonhard Gruber
Leonhard Gruber
CSChristoph Schwabl
Christoph Schwabl
KCKatharina Cima
Katharina Cima
GWGerlig Widmann
Gerlig Widmann
One year after the onset of COVID-19 pneumonia, chest CT demonstrated abnormalities, such as subtle subpleural reticulations, ground-glass opacities, or both, in 54% of participants. Background The long-term pulmonary sequelae of COVID-19 is not well known. Purpose To characterize patterns and rates of improvement of chest CT abnormalities 1 year after COVID-19 pneumonia. Mater...

7 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
SSSabina Sahanic
Sabina Sahanic
PTPiotr Tymoszuk
Piotr Tymoszuk
DADietmar Ausserhofer
Dietmar Ausserhofer
VRVerena Rass
Verena Rass
ITIvan Tancevski
Ivan Tancevski
JLJudith Loeffler-Ragg
Judith Loeffler-Ragg
BACKGROUND Long COVID, defined as presence of COVID-19 related symptoms 28 days or more after the onset of acute SARS-CoV-2 infection, is an emerging challenge to healthcare systems. The objective of this study was to phenotype recovery trajectories of non-hospitalized COVID-19 individuals. METHODS We performed an international, multi-center, exploratory online survey study on demographics, comorbidities, COVID-19 symptoms and recovery status of non-hospitalized SARS-CoV-2 infected adults (Austria: n=1157), and Italy: n= 893). RESULTS Working age subjects (Austria median: 43 yrs (IQR: 31 – 53), Italy: 45 yrs (IQR: 35 – 55)) and females (65.1% and 68.3%) predominated the study cohorts. Course of acute COVID-19 was characterized by a high symptom burden (median 13 (IQR: 9 – 18) and 13 (7 – 18) out of 44 features queried), a 47.6 – 49.3% rate of symptom persistence beyond 28 days and 20.9 – 31.9% relapse rate. By cluster analysis, two acute symptom phenotypes could be discerned: the non-specific infection phenotype and the multi-organ phenotype (MOP), the latter encompassing multiple neurological, cardiopulmonary, gastrointestinal and dermatological features. Clustering of long COVID subjects yielded three distinct subgroups, with a subset of 48.7 – 55 % long COVID individuals particularly affected by post-acute MOP symptoms. The number and presence of specific acute MOP symptoms and pre-existing multi-morbidity was linked to elevated risk of long COVID. CONCLUSION The consistent findings of two independent cohorts further delineate patterns of acute and post-acute COVID-19 and emphasize the importance of symptom phenotyping of home-isolated COVID-19 patients to predict protracted convalescence and to allocate medical resources. Question Which acute symptom patterns of acute COVID-19 are associated with prolonged symptom persistence, symptom relapse or physical performance impairment? Findings In this multicenter international comparative survey study on non-hospitalized SARS- CoV-2 infected adults (Austria: n = 1157, Italy: n = 893) we identified distinct and reproducible phenotypes of acute and persistent features. Acute multi-organ symptoms including neurological and cardiopulmonary manifestations are linked to elevated risk of long COVID. Meaning These findings suggest to employ symptom phenotyping of home-isolated COVID-19 patients to predict protracted convalescence and to allocate medical resources.

11 May 2016 in Pneumologie
Verified
Journal Article
Closed access
ERE Rieger
E Rieger
TSThomas Sonnweber
Thomas Sonnweber
KCK Cima
K Cima
GWG Weiss
G Weiss
JLJ Löffler-Ragg
J Löffler-Ragg
Background: There is increasing interest in the role of iron homeostasis in the natural history of pulmonary arterial hypertension (PAH). In our study we describe a work-up of iron status in a heterogeneous "real-life" PAH cohort according to different definitions of iron deficiency (ID). Material and methods: In a retrospective study in 84 patients with PAH the presence of ID was assessed according to four different definitions: (1) soluble transferrin receptor (sTfR) > 2.07 mg/l, (2) ferritin < 30ug/l and transferrin saturation < 15%, (3) ferritin < 100ug/l and transferrin saturation < 20% and (4) an elevated ferritin-index (sTfR)/logFerritin dependent on CRP, respectively. Iron data were related to 6MWD, NYHA class, duration of disease, hemodynamic measurements, hemoglobin level (gender dependent), NT-proBNP, gender and to ABG values. Results:All PAH patients (100%) displayed an elevated sTfR value. According to definition (2) 90.1% were iron sufficient and 9.9% were iron deficient. The criteria for ID in (3) displayed 63% of PAH patients to be iron sufficient, whereas 37.0% were iron deficient. The CRP dependent ferritin index (4) revealed 61,7% patients with normal iron status and 38,3% showed ID. In (2), gender (p = 0,008) differed between the two groups. Definition (3) showed a significant difference in 6MWD (p = 0.005), NYHA class (p = 0.047), PVR (p = 0.009) and gender (p = 0,046). According to the Ferritin-Index (4), NYHA functional class (p = 0,018), anemia (men) (p = 0,010) and NT-proBNP (p = 0.016) differed between the groups. Discussion:The diagnostic analyses of iron status in our cohort of PAH patients shows pronounced differences in frequencies of ID depending on its definition. This observation has to be taken into account when interpreting the results of individual patients. It is still unclear whether ID has a causal relationship to PAH or is an epiphenomenon. The issue of the most suitable definition of ID in PAH further complicates the selection of appropriate patients for iron supplementation.